Skip to main content

Table 7 Survival in trials comparing gemcitabine to gemcitabine plus fluoropyrimidine

From: Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

Reference

Year

Treatment regimen

Median survival (mo)

p

HR

95% CI

Berlin

2002

Gemcitabine

5.4

0.09

0.82

0.65 – 1.03

  

Gemcitabine + 5-FU (bolus)

6.7

   

Riess

2005

Gemcitabine

6.2

0.68

1.04

0.86 – 1.25

  

Gemcitabine + 5-FU (infusional)

5.9

   

DiCostanzo

2005

Gemcitabine

7.8

--

na

na

  

Gemcitabine + 5-FU (CI)

7.5

   

Scheithauer

2003

Gemcitabine

8.2

--

0.82

0.50 – 1.35

  

Gemcitabine + Capecitabine

9.5

   

Herrmann

2005

Gemcitabine

7.3

0.314

0.89

0.70 – 1.12

  

Gemcitabine + Capecitabine

8.4

   

Cunningham

2005

Gemcitabine

6.0

0.026

0.79

0.65 – 0.97

  

Gemcitabine + Capecitabine

7.4

   
  1. 5-FU: 5-fluorouracil; CI = continuous infusion; na = data not available;